AbCellera Biologics Inc. (ABCL)
NASDAQ · Healthcare
AbCellera Biologics Inc. Income Statement 2019–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenue | 75.1M | 28.8M | 38.0M | 485.4M | 375.2M | 233.2M | 11.6M |
| Gross Profit | — | — | — | — | — | — | — |
| Profitability | |||||||
| Operating Income | -217.1M | -314.8M | -237.2M | 216.5M | 204.4M | 156.0M | -4.1M |
| EBITDA | — | — | — | — | — | — | — |
| Net Income | -146.4M | -162.9M | -146.4M | 158.5M | 153.5M | 118.9M | -2.2M |
| Per Share Data | |||||||
| EPS (diluted) | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 299M | 294M | 289M | 315M | 318M | 263M | 151M |
AbCellera Biologics Inc. Income Statement — FAQ
AbCellera Biologics Inc. (ABCL) income statement over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ABCL's income statement history?
The chart and table above show AbCellera Biologics Inc.'s income statement by year and by quarter, including the growth rate.